Literature DB >> 27454855

A single Mediterranean meal does not impair postprandial flow-mediated dilatation in healthy men with subclinical metabolic dysregulations.

Sébastien Lacroix1,2,3, Christine Des Rosiers1,2,3, Mathieu Gayda1,2,4, Anna Nozza5, Éric Thorin2,6, Jean-Claude Tardif2,4, Anil Nigam1,2,3,4.   

Abstract

Cardiovascular risk factors are known to exacerbate high-saturated fatty acid meal (HSFAM)-induced endothelial dysfunction, but the influence of subclinical metabolic dysregulations and the acute impact of a single mixed Mediterranean-type meal (MMM) remains unknown. Thus, this study has the objective to evaluate the metabolic and vascular effect of such meals in healthy subjects with or without subclinical fasting metabolic dysregulations. Twenty-eight healthy males without overt cardiovascular risk factors randomly ingested 1 of 2 isocaloric meals on separate days. Plasma metabolic markers, fatty acid (FA) profile, and endothelial function (flow-mediated dilatation; FMD) were assessed at baseline and 2 and 4 h after meal ingestion. Unsupervised hierarchical clustering identified 2 subgroups of participants (n = 11 and 17) differing by their baseline metabolic profiles. The MMM did not significantly alter postprandial endothelial function in all subjects, irrespective of baseline metabolic parameters. In contrast, the HSFAM induced postprandial endothelial dysfunction (Δ%FMDabsolute = -5.28 ± 2.54, p < 0.01 vs. MMM) in a subgroup of individuals with significantly greater body mass index, fasting insulinemia, and lipid parameters (n = 11). Finally, the postprandial plasma FA profiles were differentially enriched by the HSFAM and MMM, notably with saturated FAs and omega-3 polyunsaturated FAs, respectively. Collectively, our results highlight the detrimental impact of a single HSFAM on endothelial function in healthy individuals displaying subclinical fasting metabolic dysregulations. Such individuals could benefit from MMM, demonstrated herein to be without any acute detriment to endothelial function.

Entities:  

Keywords:  cardiovascular disease risk factors; composition d’acides gras plasmatiques; endothelial function; facteurs de risque de maladie cardiovasculaire; fonction endothéliale; inflammation; oxidative stress; plasma fatty acid composition; stress oxydatif

Mesh:

Substances:

Year:  2016        PMID: 27454855     DOI: 10.1139/apnm-2015-0490

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  5 in total

1.  A single, high-fat meal adversely affects postprandial endothelial function: a systematic review and meta-analysis.

Authors:  Juanita J Fewkes; Nicole J Kellow; Stephanie F Cowan; Gary Williamson; Aimee L Dordevic
Journal:  Am J Clin Nutr       Date:  2022-09-02       Impact factor: 8.472

2.  Avocado Fruit on Postprandial Markers of Cardio-Metabolic Risk: A Randomized Controlled Dose Response Trial in Overweight and Obese Men and Women.

Authors:  Eunyoung Park; Indika Edirisinghe; Britt Burton-Freeman
Journal:  Nutrients       Date:  2018-09-12       Impact factor: 5.717

Review 3.  The Postprandial Appearance of Features of Cardiometabolic Risk: Acute Induction and Prevention by Nutrients and Other Dietary Substances.

Authors:  Laurianne Dimina; François Mariotti
Journal:  Nutrients       Date:  2019-08-21       Impact factor: 5.717

4.  Meal-exercise challenge and physical activity reduction impact on immunity and inflammation (MERIIT trial).

Authors:  Diana Silva; Rita Moreira; Oksana Sokhatska; Marília Beltrão; Tiago Montanha; Vanessa Garcia-Larsen; Rodrigo Villegas; Milton Severo; Andreia Pizarro; Mariana Pinto; Carla Martins; Ana Duarte; Luís Delgado; João Rufo; Inês Paciência; João Paulo Teixeira; Carla Costa; Pedro Moreira; Joana Carvalho; André Moreira
Journal:  Contemp Clin Trials Commun       Date:  2018-05-09

Review 5.  A Comprehensive Review of Hass Avocado Clinical Trials, Observational Studies, and Biological Mechanisms.

Authors:  Mark L Dreher; Feon W Cheng; Nikki A Ford
Journal:  Nutrients       Date:  2021-12-07       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.